• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Perspective of targeting tumor microenvironment in non-small-cell lung cancer

Research Project

Project/Area Number 15H04943
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Respiratory surgery
Research InstitutionOsaka University

Principal Investigator

shintani yasushi  大阪大学, 医学系研究科, 准教授 (90572983)

Co-Investigator(Kenkyū-buntansha) 南 正人  大阪大学, 医学部附属病院, 准教授 (10240847)
川村 知裕  大阪大学, 医学系研究科, 助教 (30528675)
奥村 明之進  大阪大学, 医学系研究科, 教授 (40252647)
舟木 壮一郎  大阪大学, 医学系研究科, 講師 (50464251)
井上 匡美  京都府立医科大学, 医学(系)研究科(研究院), 教授 (10379232)
Project Period (FY) 2015-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥16,770,000 (Direct Cost: ¥12,900,000、Indirect Cost: ¥3,870,000)
Fiscal Year 2017: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2016: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2015: ¥7,280,000 (Direct Cost: ¥5,600,000、Indirect Cost: ¥1,680,000)
Keywords肺癌 / 癌周囲微小環境 / 上皮間葉移行 / 癌幹細胞 / 癌関連線維芽細胞 / 抗線維化剤 / IL-6 / TGF-β / 癌幹細胞様形質 / 肺癌治療 / 薬剤耐性
Outline of Final Research Achievements

The tumor microenvironment is composed of different types of stromal cells that represent a key component of tumor progression. We have reported that TGF-β signaling mediates epithelial mesenchymal transition (EMT) in non-small-cell lung cancer (NSCLC) cells. In order to identify new targets for prevention of metastasis, it is important to understand the molecular mechanisms that drive EMT. Interaction between cancer-associated fibroblasts (CAFs) and tumor cells have shown increased tumor cell survival via several pathways including EMT. We showed that IL-6 from CAFs enhanced TGF-β induced EMT in NSCLC cells. Furthermore, an anti-fibrotic agent significantly inhibited production of IL-6 or TGF-β1 of CAFs, resulting in inhibition of the EMT change in NSCLC cells. In in vivo examination, the anti-fibrotic agent also suppressed the tumor progression. Targeting CAFs as a therapeutic strategy against cancer is an intriguing concept that would benefit from further study.

Report

(4 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Annual Research Report
  • 2015 Annual Research Report
  • Research Products

    (26 results)

All 2018 2017 2016 2015

All Journal Article (11 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 11 results,  Open Access: 3 results,  Acknowledgement Compliant: 3 results) Presentation (15 results) (of which Int'l Joint Research: 4 results)

  • [Journal Article] 肺癌周囲微小環境を標的としたがん治療2018

    • Author(s)
      新谷康、奥村明之進
    • Journal Title

      日本外科学会雑誌

      Volume: 印刷中

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Stromal PDGFR-β Expression is Associated with Postoperative Survival of Non-Small Cell Lung Cancer Patients Receiving Preoperative Chemo- or Chemoradiotherapy Followed by Surgery2018

    • Author(s)
      Kanzaki Ryu、Ose Naoko、Kawamura Tomohiro、Funaki Soichiro、Shintani Yasushi、Minami Masato、Takakura Nobuyuki、Okumura Meinoshin
    • Journal Title

      World Journal of Surgery

      Volume: 印刷中 Issue: 9 Pages: 2879-2886

    • DOI

      10.1007/s00268-018-4560-7

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Gas6 derived from cancer-associated fibroblasts promotes migration of Axl-expressing lung cancer cells during chemotherapy.2017

    • Author(s)
      Kanzaki R, Naito H, Kise K, Takara K, Eino D, Minami M, Shintani Y, Funaki S, Kawamura T, Kimura T, Okumura M, Takakura N.
    • Journal Title

      Scientific Reports

      Volume: 7 Issue: 1 Pages: 10613-10613

    • DOI

      10.1038/s41598-017-10873-2

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.2017

    • Author(s)
      Kusumoto H, Shintani Y, Kanzaki R, Kawamura T, Funaki S, Minami M, Nagatomo I, Morii E, Okumura M.
    • Journal Title

      Cancer Sci.

      Volume: 108 Issue: 3 Pages: 528-535

    • DOI

      10.1111/cas.13142

    • Related Report
      2017 Annual Research Report 2016 Annual Research Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer.2017

    • Author(s)
      Fujiwara A, Shintani Y, Funaki S, Kawamura T, Kimura T, Minami M, Okumura M.
    • Journal Title

      Lung Cancer.

      Volume: 106 Pages: 8-16

    • DOI

      10.1016/j.lungcan.2017.01.006

    • Related Report
      2017 Annual Research Report 2016 Annual Research Report
    • Peer Reviewed / Int'l Joint Research / Acknowledgement Compliant
  • [Journal Article] Clinicopathological Significance of Epithelial Mesenchymal Transition in Thymic Cancer2017

    • Author(s)
      新谷康、舟木壮一郎、川村知裕、大瀬尚子、神崎 隆、南 正人、森井英一、奥村明之進
    • Journal Title

      Haigan

      Volume: 57 Issue: 6 Pages: 746-751

    • DOI

      10.2482/haigan.57.746

    • NAID

      130006847816

    • ISSN
      0386-9628, 1348-9992
    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling.2016

    • Author(s)
      Shintani Y, Fujiwara A, Kimura T, Kawamura T, Funaki S, Minami M, Okumura M
    • Journal Title

      J Thorac Oncol.

      Volume: 11 Issue: 9 Pages: 1482-92

    • DOI

      10.1016/j.jtho.2016.05.025

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] PSF1 (Partner of SLD Five 1) is a Prognostic Biomarker in Patients with Non-small Cell Lung Cancer Treated with Surgery Following Preoperative Chemotherapy or Chemoradiotherapy.2016

    • Author(s)
      Kanzaki R, Naito H, Kise K, Takara K, Eino D, Minami M, Shintani Y, Funaki S, Kawamura T, Kimura T, Okumura M, Takakura N.
    • Journal Title

      Ann Surg Oncol.

      Volume: 23 Pages: 4093-4100

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Multimodality treatment for advanced thymic carcinoma: outcomes of induction therapy followed by surgical resection in 16 cases at a single institution.2015

    • Author(s)
      Shintani Y,Inoue M, Kawamura T, Funaki S, Minami M, Okumura M
    • Journal Title

      Gen Thorac Cardiovasc Surg.

      Volume: 63 Issue: 3 Pages: 159-163

    • DOI

      10.1007/s11748-014-0486-7

    • Related Report
      2015 Annual Research Report
    • Peer Reviewed
  • [Journal Article] B-type natriuretic peptide-guided risk assessment for postoperative complications in lung cancer surgery2015

    • Author(s)
      Nojiri T,Inoue M, Shintani Y, Takeuchi Y, Maeda H, Hamasaki T, Okumura M
    • Journal Title

      World J Surg.

      Volume: 39 Issue: 5 Pages: 1092-8

    • DOI

      10.1007/s00268-015-2943-6

    • Related Report
      2015 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells.2015

    • Author(s)
      Nojiri T, Hosoda H, Tokudome T, Miura K, Ishikane S, Otani K, Kishimoto I, Shintani Y, Inoue M, Kimura T, Sawabata N, Minami M, Nakagiri T, Funaki S, Takeuchi Y, Maeda H, Kidoya H, Kiyonari H, Shioi G, Arai Y, Hasegawa T, Takakura N, Hori M, Ohno Y, Miyazato M, Mochizuki N, Okumura M, Kangawa K
    • Journal Title

      Proc Natl Acad Sci USA

      Volume: 112 Issue: 13 Pages: 4086-4091

    • DOI

      10.1073/pnas.1417273112

    • Related Report
      2015 Annual Research Report
    • Peer Reviewed / Open Access
  • [Presentation] Clinicopathological Significance of Epithelial Mesenchymal Transition in Thymic Cancer2017

    • Author(s)
      Shintain Y, Funaki S, Ose N, Kawamura T, Kanzaki R, Minami M, Morii E, Okumura M
    • Organizer
      World Conference on Lung Cancer
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Prognostic impact of Programmed cell death-1 (PD-1) tumor-infiltrating lymphocytes and Programmed cell death-1 -ligand 1 (PD-L1) expression in thymic cancer2017

    • Author(s)
      Funaki S, Shintani Y, Ose N, T Kawamura T, Kanzaki R, Minami M, and Okumura M
    • Organizer
      World Conference on Lung Cancer
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Stromal PDGFR-β expression influences postoperative survival of NSCLC patients receiving preoperative chemo- or chemo-radiotherapy2017

    • Author(s)
      Kanzaki R, Naito H, Eino D, Kawamura T, Ose N, Funaki S, Shintani Y, Minami M,Okumura M, Takakura N.
    • Organizer
      World Conference on Lung Cancer
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 非小細胞性肺癌におけるPD-L1発現制御について2017

    • Author(s)
      舟木壮一郎、福井新谷 絵里子、川村知裕、神崎 隆、康、南 正人、奥村明之進
    • Organizer
      第117回日本外科学会定期学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] 免疫チェックポイント経路PD-1/PD-L1の発現制御による肺癌治療法の確立2017

    • Author(s)
      舟木壮一郎、福井絵里子、川村知裕、神崎 隆、新谷 康、南 正人、奥村明之進
    • Organizer
      第34回日本呼吸器外科学会総会
    • Related Report
      2017 Annual Research Report
  • [Presentation] 肺腺癌におけるPodocalyxin発現と腫瘍悪性化の検討2016

    • Author(s)
      楠本英則、新谷康、木村亨、川村知裕、舟木壮一郎、南正人、奥村明之進
    • Organizer
      日本呼吸器外科学会総会(33)
    • Place of Presentation
      京都
    • Related Report
      2016 Annual Research Report
  • [Presentation] 肺腺癌におけるPODXL発現とEMT誘導の検討2016

    • Author(s)
      楠本英則、新谷康、木村亨、川村知裕、舟木壮一郎、南正人、奥村明之進
    • Organizer
      日本肺癌学会学術集会(57)
    • Place of Presentation
      福岡
    • Related Report
      2016 Annual Research Report
  • [Presentation] 肺癌細胞におけるピルフェニドンのEMT抑制を介した治療効果と抗癌剤の作用増強効果についての検討2016

    • Author(s)
      藤原綾子、新谷康、舟木壮一郎、川村知裕、福井絵里子、南正人、奥村明之進
    • Organizer
      日本外科学会定期学術集会(116)
    • Place of Presentation
      大阪
    • Related Report
      2016 Annual Research Report
  • [Presentation] 肺癌細胞におけるピルフェニドンのEMT抑制を介した治療効果と抗癌剤の作用増強効果2016

    • Author(s)
      藤原綾子、新谷康、舟木壮一郎、川村知裕、福井絵里子、南正人、奥村明之進
    • Organizer
      日本肺癌学会学術集会(57)
    • Place of Presentation
      福岡
    • Related Report
      2016 Annual Research Report
  • [Presentation] 非小細胞肺癌におけるPodocalyxinの臨床学的意義2015

    • Author(s)
      楠本英則、新谷 康、川村知裕、舟木壮一郎、井上匡美、別所俊哉、南 正人、奥村明之進
    • Organizer
      第56回日本肺癌学会学術集会
    • Place of Presentation
      横浜
    • Year and Date
      2015-11-26
    • Related Report
      2015 Annual Research Report
  • [Presentation] 肺癌細胞株におけるピルフェニドンによる抗腫瘍効果の検討2015

    • Author(s)
      藤原綾子、新谷 康、別所俊哉、舟木壮一郎、川村知裕、井上匡美、南 正人、奥村明之進
    • Organizer
      第56回日本肺癌学会学術集会
    • Place of Presentation
      横浜
    • Year and Date
      2015-11-26
    • Related Report
      2015 Annual Research Report
  • [Presentation] ANPの血管保護作用による術後再発予防効果 -前向き多施設臨床研究開始に向けて-2015

    • Author(s)
      野尻崇、細田洋司、徳留健、三浦浩一、新谷康、木村亨、井上匡美、南正人、竹内幸康、前田元、宮里幹也、寒川賢治、奥村明之進
    • Organizer
      第53回日本癌治療学会学術集会
    • Place of Presentation
      京都
    • Year and Date
      2015-10-29
    • Related Report
      2015 Annual Research Report
  • [Presentation] 上皮間葉転換EMTを標的とした肺癌治療の開発2015

    • Author(s)
      新谷康、藤原綾子、木村 亨、川村知裕、舟木壮一郎、井上匡美、南 正人、奥村明之進
    • Organizer
      第68回日本胸部外科学会定期学術集会
    • Place of Presentation
      神戸
    • Year and Date
      2015-10-17
    • Related Report
      2015 Annual Research Report
  • [Presentation] Activation of TGF β-IL6 axis mediates chemoresistance in non-small cell lung cancer by increasing epithelial-mesenchymal transition signaling2015

    • Author(s)
      Shintani Y,Funaki S, Kimura T, Fujiwara A, Kawamura T, Bessho T, Inoue M, Minami M, Okumura M
    • Organizer
      AACR annual meeting 2015
    • Place of Presentation
      Philadelphia,United States of America
    • Year and Date
      2015-04-22
    • Related Report
      2015 Annual Research Report
    • Int'l Joint Research
  • [Presentation] cT4肺癌切除症例の治療成績2015

    • Author(s)
      新谷康、楠本英則、井上匡美、別所俊哉、舟木壮一郎、川村知裕、南 正人、奥村明之進
    • Organizer
      第115回日本外科学会定期学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2015-04-16
    • Related Report
      2015 Annual Research Report

URL: 

Published: 2015-04-16   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi